Trial Profile
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 22 Aug 2009 New trial record